Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.

Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.